chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Systemic: Dizziness / Lightheadness-Mild, Systemic: Blurry vision, severe-Severe, Systemic: Headache-Mild, Additional Details: Patient received her second vaccine dose at 10:34am on 6/15/21. She returned to the pharmacy at 4:08pm alert and oriented to complain of blurry vision. She was unable to open her eyes completely and stated that she started having blurry vision at around 1pm that day. In addition to the blurry vision, patient stated having a headache and feeling light headed. She denied any difficulty breathing or swelling of the mouth/throat. Immediate medical attention was recommended but denied by patient.
unstoppable crying, temp elevation 4AM seen in ER temp 104 treated w/Pediprofen; cont crying, no sleep;
L side of neck swollen lymph node tender larger than a quarter, not warm, not reddened, firm to touch.
HYPOTENSION 6/12/2022 HX OF C DIFFICILE  HYPOXIA 6/7/2022 HX OF C DIFFICILE  HYPOTENSION 6/12/2022 ACUTE UTI  HYPOXIA 6/7/2022 ACUTE UTI  HYPOTENSION 6/12/2022 UNSPECIFIED DEMENTIA, UNSPECIFIED SEVERITY, W OTHER BEHAVIORAL DISTURBANCE  HYPOXIA 6/7/2022 UNSPECIFIED DEMENTIA, UNSPECIFIED SEVERITY, W OTHER BEHAVIORAL DISTURBANCE
having some trouble swallowing; aches; something to do with my tonsils. I hesitate to say they are enlarged as I went to urgent care; chills; This is a spontaneous case received from a contactable consumer (patient). A 22-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot/batch number was not reported) via an unspecified route of administration in left arm on 12Feb2021 14:00 (age at vaccination 22-year-old and patient was not pregnant at the time of vaccination) as DOSE 2, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medication were not reported. The patient past drug event included known allergies to ceftriaxone. The patient historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunisation. Other vaccine in four weeks was reported as none. On 12Feb2021 20:00, the patient stated that she noticed she was having some trouble swallowing. This was also about the time other side effects (aches, chills) began setting in but those all subsided within 24 hours. The swallowing problem had persisted. It was hard to explain the exact feeling but she cannot always swallow on command. She does not had a sore throat, but she does think it could have something to do with her tonsils. She hesitates to say they are enlarged as she went to urgent care on 16Feb. The patient underwent procedure which included throat and lymph nodes were checked and results was normal. The patient did not have COVID prior vaccination. COVID tested post vaccination was reported as none. AE resulted in emergency room/department or urgent care. No treatment was received for the adverse events. Outcome of the event was recovered for aches and chills 2021 and not recovered for other events.  Follow-up attempts are completed. No further information was expected.
This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on 05Feb2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Reporter is a consumer who received her first dose of Pfizer-BioNTech Covid19 vaccine 05Feb2021, then tested positive for Covid19 infection 20Feb2021. She reports a mild infection, few to no symptoms. She is due for her second dose of vaccine on 26Feb2021 and wants to know if she should receive it as scheduled. The outcome of the events was unknown. Information on the lot/batch number has been requested.
When presented to clinic for dose #2 she states that shortly after dose #1 she had numbness on the left side of her face extending down her left arm.  The numbness lasted approx 3 hours.  Her PCP did recommend she receive dose #2.
Fever started 9/25 elevated 104 - seen in office 9/26/11. CBC WBC 5.3 Mono 20. Returned office 9-29-11. Rash started 9/28 trunk/face, fever now low grade. Strep test negative. Dx viral exanthem vs vaccine reaction.
Red blotch on arm near injection site. Blotch is raised and mildly painful to touch. Skin is hot in blotch area.
Patient given vaccine that same evening started with nausea and fever 102. Next morning with RUE soreness and trouble lifting arm. Since back in office 9/18/13 2 PM. Area erythema calor, tenderness at lateral aspect of the deltoid. Tenderness to any motion. She states unable to do her job. Treated for cellulitis. Given cephalexin 500 mg QID x 10 days and Hydrocodone/Acetaminophen 5/325 1 QID PRN. Pt returned 9/20/2013 to recheck states no change in symptoms. Pain, fever, erythema, decreased ROM with productive cough, sore throat, head congestion, headache. Patient using ice and Tylenol without relief. Advised continue ice, antibiotic. Use Ibuprofen and Hydrocodone/Acetaminophen as needed. CBC with Diff ordered today.
Pt experienced a local rash at site of injection. Lightheadedness and weakness about 20 minutes post vax. No shortness of breath or other problems. Pt's mom was at the school volunteering and she transported child to the pediatrician. MD gave Benadryl by mouth, assesses and released to mom's care or back to school. Physicians order states no more Hep B vaccines to be given.
Started the afternoon of 12/30/2020 a headache then by evening I started to have an upset stomach. Next day this continued only more severe plus I had chills and fever. Then I started to have dry heaves and all symptoms continued for 4 days. Also was light headed and arm soreness but that was least of my worries.
Autoimmune disease-Hyperthyroidism my heart has accelerated and I felt that I couldn?t breath much a few weeks after the vaccine I then went to visit my primary care doctor, found my thyroid unbalanced then she referred me to an endocrinologist.
Information has been received from a health professional concerning a 35 month old male who on 7/13/99 was vaccinated with 1 dose of varicella virus vaccine live (site unknown) (lot 629899/0113J). Subsequently, it was reported that on 6/1/01, the pt was dx'd with "a mild case of chicken pox". Unspecified medical attention was sought. It was reported that in the spring of 2001, there was a very large chicken pox outbreak in the area. It was not specified whether or not the pt had an exposure to these cases. The reporter also indicated that the pt was not given close to the expiration date and that vaccine lot numbers were not similar in the other cases reported. Subsequently, the pt recovered. No further information is available.
Very sore muscle that has not gone away. Reduce mobility in arm. Can't not hold heavy things.
When pulling out medication did not mix powder with diluent inadvertently gave the diluent not the vaccine medication to client. Powder portion of vaccine was not administered to client.
In early May my 2nd Moderna vaccine shot caused a typical flu like symptom for 48 hours and then back to normal.   About a month has passed and on June 11th I have started to feel like I had a sore throat, then the next day and since then I have an intense pain around my thyroid area  when swallowing and it feels sore to the touch.  My doctors office has taken swabs for flu and bacteria which have come up negative, and I am waiting on a Covid test which I presume will also be negative.  Currently they diagnosed me with Pharyngitis, and I believe that it is subacute thyroiditis as a reaction from the vaccine. I have not been sick or come in contact with any sick people, and have worn a mask everywhere out of my home.
Information has been received from an RN concerning a 17 month old white female who on 11/23/99, was vaccinated with the 1st dose of MMR. She also had Haemophilus b the same day. On 12/14/99, the pt experienced measles rash composed of pink dots. The rash was flat, erythematous and non-petechial. It was located on the abdomen and chest with some lesions on the upper arms and thighs. The rash persisted for 3 days. She was seen by a physician. On 12/17/99, the pt recovered from the measles rash. No further information is available.
muscle soreness, myalgia, DOE with walking in her home and even down the hall, nausea, poor apetite, fatigue, and needs naps a lot
onset paresthesia & numbness in feet 24NOV; devel weakness & hospitalized 6DEC90; dx GBS now recovering;
around or just after my first Covid-19  vaccine on December 18 I experienced mild wrist pain . At the time I thought that the symptoms were likely due to overuse from  resistance  exercise .  The symptoms did not improve after a change in exercise routine. On January 5, I experienced left knee pain after exercising on an elliptical machine. I received my second Covid-19 vaccine on January 8. Subsequently I experienced severe joint pains and muscle aches for 2 days. The severe pain subsided somewhat, but I then developed a symmetrical polyarthritis involving my wrists, elbows, ankles and knees with marked knee effusions.  i experienced severe morning stiffness. I was ultimately diagnossed with sero-negative rheumatoid arthritis
Patient is nursing baby . The baby developed rash 5 hours after mother received Moderna vaccination both doses. The rash lasted about 15 minutes and went away. No other symptoms for mom or baby. Mother did not report first dose rash.
My understanding is I am experiencing a delayed hypersensitivity reaction. On day 8 after receiving vaccination had pain at the injection site, similar to the pain after receiving the injection. Injection area was swollen, warm, and very red. The size was about 3" in diameter. Day 9, same as day 8, but the diameter had increased to about 6". Today is day 10. So far diameter is the same  and area is itching.
I gave an HPV vaccine, within one minute, her body jerked and she passed out, I layed her down. Within 30 seconds, she was awake.
Bumps to arms, legs, private area itches. On 4.15.11 rash getting worse. Seen in ER. Rash spreading saw Dr. on 4-18-11 was told it was a reaction from the shots.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An 80-year-old female patient received BNT162b2 (BNT162B2), on 09Apr2022 at 15:00 as dose 3 (booster), single (Lot number: FK9894) at the age of 80 years intramuscular, in arm for covid-19 immunisation. The patient's relevant medical history included: "Chronic Lymphocytic Leukemia", start date: 18Sep2007 (ongoing); "Spinal stenosis", start date: 2015 (unspecified if ongoing); "chemotherapy" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot Number: EW0164, Time of vaccination: 03:00 PM, Anatomical location: Upper Arm, Route of administration: Left muscle), administration date: 30Apr2021, when the patient was 79-year-old, for COVID-19 immunization; BNT162b2 (DOSE 2, SINGLE; Lot Number:EW0185, Time of vaccination: 02:00 PM, Anatomical location: Upper Arm, Route of administration: Intramuscular), administration date: 02Jul2021, when the patient was 79-year-old, for Covid-19 immunization, reaction(s): "Inappropriate schedule of vaccine administered". The following information was reported: URINARY TRACT INFECTION (non-serious) with onset 2022, outcome "unknown", described as "UTI". The patient underwent the following laboratory tests and procedures: Bone density decreased: (2021) low; Chest X-ray: (2021) good; Culture urine: (2022) UTI, notes: 4 times in 2022; Diagnostic procedure: (2007) Unknown results; Imaging procedure: (2015) Spinal stenosis.  Additional Information: The patient was diagnosed with chronic lymphocytic leukaemia (CLL) 14 years ago, this was prior to the Covid vaccines. She stated that it can start and stop and come back. She had been on oral medication and it did not work with her, she then started back on chemo. She was confused because she did have another hip sample taken and one oncologist said she had stage 4 lymphoma and her doctor now said it was still just CLL. The patient had family history of high blood pressure, heart disease, cancer, stroke; relevant to adverse events. The patient did not take the 3rd dose in Dec2021 because she forgot. The patient received third booster in upper arm. The nurse who administered booster dose advised her to have other 2 doses on 19Sep2022 and Jan2023. The patient had leukemia and her oncologist told her that no one should have more than 4 doses at this time. The patient wanted to know if she needs to get 2 more booster shots or if she should not get more than 4 in her lifetime like her oncologist recommended. This report was not serious.
teeny weeny buzzing sound in right ear , different sound in ear; woke up during a night, and could not hear/could not hear for a week; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SUDDEN HEARING LOSS (woke up during a night, and could not hear/could not hear for a week) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 19B21A and 30A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (Medical history not provided).   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced TINNITUS (teeny weeny buzzing sound in right ear , different sound in ear). In March 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SUDDEN HEARING LOSS (woke up during a night, and could not hear/could not hear for a week) (seriousness criterion medically significant). In March 2021, SUDDEN HEARING LOSS (woke up during a night, and could not hear/could not hear for a week) had resolved. At the time of the report, TINNITUS (teeny weeny buzzing sound in right ear , different sound in ear) outcome was unknown.            Concomitant product use was not provided.  Treatment included a visit to the patient's Primary Care Physician (PCP) who checked her ear and said her ear looks good, there was no wax. An appointment was scheduled for an Ear Specialist Doctor. The patient stated there are still different sounds in her right ear. Over a period of time it is getting better but still not there.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  Further information has been requested.
Headache, vomiting, swollen upper lip. Headache started at approx 3:00 pm took Tylenol. Vomited up @ 8:00 pm top lip began to swell @ 8:30 pm. Mother gave Benadryl @ 9:00. 10/16/09 Swelling decreasing no other s/sx.
Miscarriage at 6 weeks 1 day. Vaginal bleeding and decline in HCG hormone. Pregnancy not viable.
No further AEs reported,; expired dose of MMR II vaccine; This spontaneous report has been received from a medical assistant, referring to a patient of unknown gender and age. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and previous drug reactions and allergies was not provided.   On 13-APR-2021,  the patient was vaccinated with and expired dose (expired product administered)  of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II), at a dose of 1 dosage form (1 injection), lot number S031702 (has been invalid upon internal validation) and expiration date on 06-APR-2021 for prophylaxis (frequency, route of administration and anatomical location were not provided). On the same date, the patient was vaccinated with a dose of measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live(PROQUAD) (therapy type: rHA), lot number S031702 (has been valid upon internal validation), with an expiration date on 06-APR-2021 (expired product administered)  for prophylaxis (dose, frequency, route of administration and anatomical location were not provided).  No further adverse events were provided.
On 06/06/02, rash, red, splotchy, warm to touch on face, arms, trunk. Ring of erythema around one of shots on left leg and shot on right leg. Temp 99.8 deg F, decrease appetite, fluids. Per doctor to give Benadryl elivir for a few days.
White ring above the injection site about the size of a quarter; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (White ring above the injection site about the size of a quarter) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (White ring above the injection site about the size of a quarter). At the time of the report, VACCINATION SITE REACTION (White ring above the injection site about the size of a quarter) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No  concomitant medical  provided by the reporter. No treatment medication provided by the reporter.
Pt does not have any adverse symptoms. Pt was given an expired vaccine with no adverse reactions. physician and patient was notified. reached out to manufacturer and they suggested to revaccinate in 28 days. Pt is aware of this and decided that she will get the vaccine in 28 days at her local pharmacy
1/10 vaccination I was in the 15 min observation, my throat tightened up. I thought anxiety. I left and feeling never went away. Wheezing, coughing. Dr. informed me I had exercise induced asthma. called pcp 10 days later when symptoms not going away 02/2021 ENT; allergic reaction. Inhalers, antihistamines. No skin reaction tests. Suggested to get 2nd vaccine.  *still having tightness in throat
Initial report received from a physician on 25 October 2006.  A male patient (age not reported), developed swelling of the eyes and itching of the upper extremities, 1/2 hour after he received Fluzone (lot number U2199AA) on 23 October 2006.  He went to the emergency room (he works as an EMT and was at the hospital) and was treated with Prednisone and Benadryl.  He was not on any concomitant medications.  He has had similar reactions in the past but is unclear to what.  His symptoms have resolved.  Follow-up information received ion 27 December 2006 from a health care professional.  Under the description of the adverse event, the reporter had written "seasonal allergies".  No other medically relevant information was provided.
Pharmacy administered Moderna Vaccination after the vial was punctured and at room temperature for longer than 12 hours. The vial was punctured on 4/21/2022 @ 08:37 AM, which means the vial expired on 04/21/2022 @ 08:37 PM. The vial was left out overnight and was used for patients' vaccination on 04/22/2022 @ 11:12 AM. Patient has been notified and has had no adverse events related to vaccination.
Patient described that he felt like his throat was closing and was having SOB. Patient had an acute rash. Called ambulance for transfer to ER.
Patients under the age of 18 Inadvertently given their series of Moderna vaccine; A spontaneous report was received from a nurse concerning a 17-years-old female patient who received Moderna's (mRNA-1273) COVID-19 Vaccine.  The patient's medical history was not provided. No concomitant medications were provided.  The patient received her first of two planned doses of mRNA-1273 (Lot/batch number: 012L20A) on 15 Jan 2021. On 15 Feb 2021, prior to the onset of the event, the patient received their second of two planned doses of mRNA-1273 (Lot/batch number: 010M20A) for prophylaxis of COVID-19 infection.  The patient under the age of 18 Inadvertently was given her series of Moderna vaccine (inappropriate age at vaccine administration).  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  The outcome of the event the patient under the age of 18 Inadvertently given their series of Moderna vaccine was considered recovered.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age (17 year old female) for mRNA-1273 (lot number 012L20A for her first dose and lot number 010M20A for her second dose) with no associated AEs reported.
Significant arm pain day 1-2. Hurt to lift arm. Then no symptoms at all. On day 10, itchy red shape around injection site. No other symptoms. Seems to be subsiding about 7 hours after first noticed.
On and off numbness and tingling in my left arm  and hand (primarily) and also in my right hand (a few times) during the day for about 3 weeks.  Involuntary movements in my fingers in both hands.  My arms and hands still fall asleep at night and this did not happen to me before except on some rare occasion that I slept on my hand or arm.  I have been awoken by a limb that is asleep about 4 times since my vaccine.  Intermittent headaches for about two week after the vaccine and a very unusual, heavy and somewhat painful period with several large clots the size of a half dollar and lasting much longer than a normal period.  I felt dizzy and lightheaded for about a day.  I  have never had these kinds of periods before.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.   A 37 year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 31Mar2021 11:00 (Lot number: EP6955) at the age of 37 years as dose 2, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1; lot number=EL3247; administration time=11:00 AM; vaccine location=Left arm,), administration date: 10Mar2021, when the patient was 37 years old, for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 31Mar2021 21:00, outcome "recovering", described as "Soreness in arm"; VACCINATION SITE PAIN (non-serious) with onset 31Mar2021 21:00, outcome "recovering", described as "Soreness at injection site"; PAIN (non-serious) with onset 31Mar2021 21:00, outcome "recovering", described as "Body aches all over". Therapeutic measures were not taken as a result of pain in extremity, vaccination site pain, pain.   No follow-up attempts are possible. No further information is expected.